Kidney Diseases

|

10

Farxiga Cuts Risk of Kidney Disease in Patients with Type 2 Diabetes

Astra Zeneca announced promising results of a phase 3 trial of Farxiga, which showed to reduce the progression of kidney disease or renal death in …

|

FDA Gives INVOKANA® Priority Review to Treat Chronic Kidney Disease in Patients with T2D

Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the …

|

FDA Grants Breakthrough Device Designation to AI-Enabled Diagnostic for Kidney Disease

Renalytix AI, a company developing of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that it has been granted …

|

Study: Drug Reduces Risk of Kidney Failure in People with Diabetes

A new landmark clinical trial from Standford Medicine shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes …

| |

Janssen Submits sNDA for INVOKANA® for Chronic Kidney Disease in Patients with Type 2 Diabetes

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

|

FDA Approves Expanded Indication for dapagliflozin in Type 2 Diabetes, Kidney Disease

The U.S. Food and Drug Administration (FDA) has approved a label update for AstraZeneca’s FARXIGA® (dapagliflozin) and XIGDUO® XR …

|

Vitamin B Supplements May Protect Kidney Function in Children with Diabetes

Vitamin B supplements have a protective effect on kidney function in children and adolescents with Type 1 diabetes, according to new research. The …

Treatment Options for Kidney Failure

The kidneys are vital organs in the human body and are responsible for “cleaning” blood of waste and toxins. If you have diabetes and …

Cardiovascular Disease Related to Type 2 Diabetes Can Be Reduced Significantly

Proper treatment and refraining from smoking can significantly reduce the risk of cardiovascular disease resulting from Type 2 diabetes, a new …

| | | |